Vir Biotechnology announced promising results Wednesday for a pair of cancer treatments, and Vir stock catapulted by double ...

ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an ...

This is the second volume of the Research Topic titled 'Novel Insights into CAR T-cell Associated Neurotoxicity'. You may ...

Cabaletta Bio’s financials and CAR T-cell therapy show potential but face risks. Discover why CABA stock is a risky yet ...

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...